Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenobamate in Photosensitive Epilepsy
NCT00616148Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Aug 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in epilepsy comparing Placebo with YKP3089 (2 arms). Primary endpoint: IPS-induced photo-paroxysmal EEG response. Started Aug 2007; status: completed.
02
Drugs
cenobamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00616148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616148.